Please ensure Javascript is enabled for purposes of website accessibility

TEDCO funds $8.4 million in stem cell research

Twenty-six stem-cell-related research projects will share $8.4 million in grant funding, the Maryland Technology Development Corp. (TEDCO) announced Friday.

The projects include research into schizophrenia, autism, diabetes, muscular dystrophy and leukemia, among other topics. tedco-logo-color-ns

The grants were made through the Maryland Stem Cell Research Fund on the recommendation of the state’s Stem Cell Research Commission, both of which are administered by TEDCO, a state-created organization that provides early-stage funding and guidance for emerging companies.

In past years, the fund has granted more than $120 million to 349 research projects.

Among this years awardees are 13 researchers and seven post-doctoral fellows from the Johns Hopkins University, two researchers and one post-doctoral fellow from the University of Maryland, two researchers from the Kennedy Krieger Institute and two companies, BioCardia Inc. and TheraCord.

The projects include a mix of pre-clinical research, research with preliminary data to support hypotheses, exploratory projects with little or no data and post-doctoral awards to work with human stem cells, according to TEDCO.